edrophonium has been researched along with Sicca Syndrome in 1 studies
Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imrich, R | 1 |
| Alevizos, I | 1 |
| Bebris, L | 1 |
| Goldstein, DS | 1 |
| Holmes, CS | 1 |
| Illei, GG | 1 |
| Nikolov, NP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome[NCT00565526] | 28 participants (Actual) | Observational | 2007-11-26 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for edrophonium and Sicca Syndrome
| Article | Year |
|---|---|
Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's Syndrome.
Topics: Adult; Autonomic Nervous System; Case-Control Studies; Cholinesterase Inhibitors; Edrophonium; Femal | 2015 |